News & articles
Our Manufacturing FacilityRadiptide operates a GMP-aligned synthesis and testing facility in Guangzhou. From raw material intake through SPPS synthesis, multi-column HPLC purification, lyophilization and nitrogen-sealed packaging, every step is documented and traceable.We support catalog cosmetic peptides and custom se
FDA Grants Fast Track to PVX108 Peanut Peptide ImmunotherapyPVX108 received FDA Fast Track designation in August 2026 as a synthetic T-cell epitope peptide therapy for peanut allergy—one of the first allergen immunotherapy programs built entirely on short peptides rather than whole extracts.
Asia-Pacific SPPS Installations Add Cosmetic Peptide Throughput for 2025–2026Asia-Pacific SPPS additions shorten cosmetic peptide lead times while raising validation expectations.
Copper Tripeptide GHK-Cu: Market Dynamics, Specification Trends, and Formulation IntegrationAn analysis of GHK-Cu demand, tightening COA specs, and formulation best practices in 2025.
